Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Developers
Trial Sites
Trials
Clinical Pipeline
Clinical Pipeline
News
Meetings
Members
Our Members
Core Group
About
Join Us
Compound
TZY-5-84
Names
Chemical Class:
Piperazine benzothiazinone
Name of Target:
DprE1
Description
Similar to PBTZ-169. MIC reported as 0.15 ug/ml. Active in vivo, orally bioavailable, 12.5 mg/kg
Related Links
2020.Guo S et al. In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against M. tuberculosis. Biomed Pharmacother. 131:110777.
Related Links